350
Views
48
CrossRef citations to date
0
Altmetric
Letters to the Editor

Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement

, , , , &
Pages 831-833 | Received 18 Nov 2008, Accepted 01 Feb 2009, Published online: 21 Jul 2009

References

  • Roden A C, Macon W R, Keeney G L, Myers J L, Feldman A L, Dogan A. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 2008; 214: 455–463
  • Wong A K, Lopategui J, Clancy S, Kulber D, Bose S. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature. Am J Surg Pathol 2008; 32: 1265–1268
  • de Jong D, Vasmel W LE, de Boer J P, Verhave G, Barbe E, Casparie M K, et al. Anaplastic large-cell lymphoma in women with breast implants. J Am Med Assoc 2008; 300: 2030–2035
  • Popplewell L, Chang K, Olevsky O, Nademanee A, Forman S. Primary anaplastic large cell lymphoma of the breast occurring in patients with silicone breast implants. Blood 2004; 104, American Society of Hematology: Abstract 4563
  • Zetti A, Rüdiger T, Konrad M A, Chott A, Simonitsch-Klupp I, Sonnen R, et al. Genomic Profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 2004; 164: 1837–1848

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.